Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Compass Group on the acquisition of Fazer Food Services from Fazer Group
Mandate

Vinge advises Compass Group on the acquisition of Fazer Food Services from Fazer Group

June 11, 2019 M&A

Fazer Food Services is a renowned food catering business in the Nordic region with operations in Finland, Sweden, Norway and Denmark, across several sectors including Business & Industry, Education, Healthcare, Seniors and Defence. with an enterprise value of approximately €475 million.

Vinge’s team consists of responsible partners Christina Kokko and Matthias Pannier as well as senior associate Anna Thoms, together with partner Daniel Rosvall, associates Fredric Reissmüller, Hampus Olsson, Christina Odengran and Marcus Eklund (M&A), Fredrika Hjelmberg (IT/Commercial Agreements), Klara Secher (IP), Maria Schultzberg, Henrik Wastenson (Tax), Lova Unge (Employment), Daniel Wendelsson (Public Procurement) and Veronika Garemark (Real Estate). 
 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025